CAMBRIDGE, Mass.--(BUSINESS WIRE)--Garuda Therapeutics (Garuda), a company creating off-the-shelf, durable blood stem cell-based cellular therapies, today announced a $62 million Series B financing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback